A Simple Trick to Improve Our Transradial Punctures

Transradial access is here to stay; that much has been clear for some time now. However, some operators still resist change and the systematic use of this technique shows great geographical dispersion. Some of its limitations are a difficulty to obtain access and the somewhat frequent occurrence of radial artery occlusion after the procedure. This study assessed a very simple resource to avoid artery occlusion: an injection of nitroglycerin at the puncture site.

Un truco sencillo para mejorar nuestras punciones radialesThis work included 188 patients undergoing transradial catheterization who were randomized to subcutaneous injection of 0.5 mL 0.1% nitroglycerin at the puncture site or a placebo. All patients were assessed through ultrasound examinations before and at 24 hours after the procedure.

 

Upon comparison of the radial artery diameter before and after the procedure, patients in the nitroglycerin-treated group presented a significantly greater diameter than patients in the placebo control group. Most importantly, the incidence of occlusion was substantially lower in the nitroglycerin-treated group (5.4% vs. 14.4%; p = 0.04).


Read also: Antiaggregation Time after Treating Bifurcations.


There were no significant differences in other complications (forearm hematoma, pseudoaneurysm, etc.).

 

Conclusion

Subcutaneous injection of nitroglycerin at the radial artery puncture site increases the radial artery diameter and reduces the incidence of radial artery occlusion post-catheterization.

 

Original title: Subcutaneous Injection of Nitroglycerin at the Radial Artery Puncture Site Reduces the Risk of Early Radial Artery Occlusion After Transradial Coronary Catheterization. A Randomized, Placebo-Controlled Clinical Trial.

Reference: Yequn Chen et al. Circ Cardiovasc Interv. 2018;11:e006571.

 

2018-08-31-NTG-subcutánea-full


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...